4.6 Article

Phylogeography of Crimean Congo Hemorrhagic Fever Virus

Journal

PLOS ONE
Volume 11, Issue 11, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0166744

Keywords

-

Funding

  1. Russian Scientific Foundation [14-15-00619]
  2. Russian Science Foundation [14-15-00619] Funding Source: Russian Science Foundation

Ask authors/readers for more resources

Crimean Congo hemorrhagic fever virus (CCHFV) is one of the most severe viral zoonozes. It is prevalent throughout Africa, Asia and southern Europe. Limited availability of sequence data has hindered phylogeographic studies. The complete genomic sequence of all three segments of 14 Crimean Congo hemorrhagic fever virus strains isolated from 1958-2000 in Russia, Central Asia and Africa was identified. Each genomic segment was independently subjected to continuous Bayesian phylogeographic analysis. The origin of each genomic segment was traced to Africa about 1,000-5,000 years ago. The virus was first introduced to South and Central Asia in the Middle Ages, and then spread to China, India and Russia. Reverse transfers of genomic segments from Asia to Africa were also observed. The European CCHFV genotype V was introduced to Europe via the Astrakhan region in South Russia 280-400 years ago and subsequently gradually spread westward in Russia, to Turkey and the Balkans less than 150 years ago. Only a few recombination events could be suggested in S and L genomic segments, while segment reassortment was very common. The median height of a non-reassortant phylogenetic tree node was 68-156 years. There were reassortment events within the European CCHFV lineage, but not with viruses from other locations. Therefore, CCHFV in Europe is a recently emerged zoonosis that represents a spillover from the global gene pool.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020

Edmilson F. de Oliveira-Filho, Otavio V. de Carvalho, Ianei O. Carneiro, Fagner D'ambroso Fernandes, Sara Nunes Vaz, Celia Pedroso, Lilian Gonzalez-Auza, Victor Carvalho Urbieta, Arne Kuehne, Rafaela Mayoral, Wendy K. Jo, Andres Moreira-Soto, Chantal B. E. M. Reusken, Christian Drosten, Carlos Brites, Klaus Osterrieder, Eduardo Martins Netto, Luiz Eduardo Ristow, Rita de Cassia Maia, Fernanda S. Flores Vogel, Nadia Rossi de Almeida, Carlos Roberto Franke, Jan Felix Drexler

Summary: Carnivores such as cats are highly susceptible to SARS-CoV-2, and cases of human-to-cat transmission have been documented in Brazil. A study in Brazil found that the overall seroprevalence of SARS-CoV-2 in domestic cats was 7.3%, with similar infection levels across different states. The study also showed that pre-existing immunity against other coronaviruses in cats did not affect their susceptibility to SARS-CoV-2.

FRONTIERS IN IMMUNOLOGY (2022)

Article Microbiology

Serological Evidence That SARS-CoV-2 Has Not Emerged in Deer in Germany or Austria during the COVID-19 Pandemic

Andres Moreira-Soto, Christian Walzer, Gabor A. Czirjak, Martin H. Richter, Stephen F. Marino, Annika Posautz, Pau De Yebra Rodo, Gayle K. McEwen, Jan Felix Drexler, Alex D. Greenwood

Summary: In contrast to North American white-tailed deer, there is no evidence of SARS-CoV-2 exposure in German and Austrian deer species, based on the pseudoneutralization assay.

MICROORGANISMS (2022)

Review Parasitology

Revisiting epidemiology of leishmaniasis in central Asia: lessons learnt

Vyacheslav Yurchenko, Daniil S. Chistyakov, Lyudmila Akhmadishina, Alexander N. Lukashev, Jovana Sadlova, Margarita Strelkova

Summary: In this study, we reviewed historical and recent data on Leishmaniaspp. infection in several countries including Turkmenistan, Uzbekistan, Kazakhstan, Kyrgyzstan, Iran, China, and Mongolia. We focused on a complex of co-existing species and their shared reservoirs and vectors. Additionally, we analyzed the presence of dsRNA viruses in these species and discussed future research directions to understand the susceptibility of different Leishmaniaspp. to viral infection.

PARASITOLOGY (2023)

Article Virology

Patterns and Temporal Dynamics of Natural Recombination in Noroviruses

Yulia A. Vakulenko, Artem V. Orlov, Alexander N. Lukashev

Summary: Noroviruses infect a wide range of mammals and are the major cause of gastroenteritis in humans. Recombination events between nonstructural (ORF1) and structural genomic regions (ORF2 and ORF3) were found in all analyzed genogroups of noroviruses, although recombination was most prominent between members of GII. The half-life times of recombinant forms of human GI and GII noroviruses were 10.4 and 8.4-11.3 years, respectively, and there was evidence of many recent recombination events.

VIRUSES-BASEL (2023)

Article Medicine, Research & Experimental

Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9

Dmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, Natalia Ponomareva, Natalia F. Zakirova, Aleksandra Egorshina, Dmitry V. Yanvarev, Ekaterina Bayurova, Anna Sudina, Irina Goptar, Anastasiya Nikiforova, Elena Dunaeva, Tatiana Lisitsa, Ivan Abramov, Anastasiia Frolova, Alexander Lukashev, Ilya Gordeychuk, Andrey A. Zamyatnin Jr, Alexander Ivanov, Vladimir Chulanov

Summary: CRISPR-Cas9 systems show remarkable anti-HBV activity by targeting the hepatitis B virus major genomic form, cccDNA. However, inactivating cccDNA alone is not enough to cure the infection, as HBV replication rebounds due to the de novo formation of cccDNA from its precursor, rcDNA. Depleting rcDNA before delivering CRISPR-Cas9 RNPs can prevent viral rebound and promote resolution of HBV infection. These findings lay the groundwork for developing a virological cure of HBV infection using a single dose of short-lived CRISPR-Cas9 RNPs, with the help of widely used reverse transcriptase inhibitors to block cccDNA replenishment.

MOLECULAR THERAPY-NUCLEIC ACIDS (2023)

Article Pharmacology & Pharmacy

Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle-Mimetic Nanovesicles Loaded with Chemotherapeutics

Sergey Brezgin, Anastasiya Kostyusheva, Natalia Ponomareva, Ekaterina Bayurova, Alla Kondrashova, Anastasia Frolova, Olga Slatinskaya, Landysh Fatkhutdinova, Georgy Maksimov, Mikhail Zyuzin, Ilya Gordeychuk, Alexander Lukashev, Sergey Makarov, Alexander Ivanov, Andrey A. Zamyatnin Jr, Vladimir Chulanov, Alessandro Parodi, Dmitry Kostyushev

Summary: Biological nanoparticles, such as extracellular vesicles (EVs) and extracellular vesicle-mimetic nanovesicles (EMNVs), have been extensively studied as drug delivery vehicles in medical applications. This study investigated the properties and drug delivery abilities of EVs and EMNVs, and analyzed their use for delivering the chemotherapeutic drug doxorubicin. EMNVs were found to be more effectively internalized, while EVs showed higher intracellular release of doxorubicin.

PHARMACEUTICS (2023)

Review Biotechnology & Applied Microbiology

Technological aspects of manufacturing and analytical control of biological nanoparticles

Sergey Brezgin, Alessandro Parodi, Anastasiya Kostyusheva, Natalia Ponomareva, Alexander Lukashev, Darina Sokolova, Vadim S. Pokrovsky, Olga Slatinskaya, Georgy Maksimov, Andrey A. Zamyatnin Jr, Vladimir Chulanov, Dmitry Kostyushev

Summary: Extracellular vesicles (EVs), cell-derived biological nanoparticles, have gained significant interest for drug delivery due to their ideal biocompatibility, safety, ability to cross biological barriers, and surface modification potential. However, the translation of EVs into practical applications has been challenging due to issues in up-scaling, synthesis, and quality control methods. Advances in manufacturing technology now allow EVs to carry various therapeutic cargoes, and new technologies have been introduced to improve EV production, isolation, characterization, and standardization.

BIOTECHNOLOGY ADVANCES (2023)

Article Infectious Diseases

Genomic analysis of Leishmania turanica strains from different regions of Central Asia

Tatiana S. Novozhilova, Daniil S. Chistyakov, Lyudmila V. Akhmadishina, Alexander N. Lukashev, Evgeny S. Gerasimov, Vyacheslav Yurchenko

Summary: The evolution of Leishmania is influenced by clonality, sexual reproduction, and geographic isolation. Leishmania turanica populations in Central Asia can be mixed with other species or monospecific and isolated. Genetic analysis revealed no significant differences in the evolution of mixed and monospecific L. turanica populations. However, there were variations in large-scale genomic rearrangements, with genome translocations being the most prominent example. Additionally, L. turanica exhibited a higher level of chromosomal copy number variation compared to its sister species L. major, suggesting active evolutionary adaptation.

PLOS NEGLECTED TROPICAL DISEASES (2023)

Article Medicine, Research & Experimental

Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus

Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, Natalia Ponomareva, Ekaterina Bayurova, Natalia Zakirova, Alla Kondrashova, Irina Goptar, Anastasiya Nikiforova, Anna Sudina, Yurii Babin, Ilya Gordeychuk, Alexander Lukashev, Andrey A. Zamyatnin Jr, Alexander Ivanov, Vladimir Chulanov

Summary: APOBEC/AID cytidine deaminases play an important role in innate immunity and antiviral defenses. Researchers developed a CRISPR-activation-based approach to induce APOBEC/AID overexpression and control its effects on HBV replication and cellular toxicity. The study highlights the potential for precise control of APOBEC/AID activation as a strategy for suppressing HBV replication without toxicity.

MOLECULAR THERAPY-NUCLEIC ACIDS (2023)

Article Immunology

A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells

Alexandra Kegler, Laura Drewitz, Claudia Arndt, Cansu Daglar, Liliana Rodrigues Loureiro, Nicola Mitwasi, Christin Neuber, Karla Elizabeth Gonzalez Soto, Tabea Bartsch, Larysa Baraban, Holger Ziehr, Markus Heine, Annabel Nieter, Andres Moreira-Soto, Arne Kuehne, Jan Felix Drexler, Barbara Seliger, Markus Laube, Domokos Mathe, Bernadett Palyi, Polett Hajdrik, Laszlo Forgach, Zoltan Kis, Krisztian Szigeti, Ralf Bergmann, Anja Feldmann, Michael Bachmann

Summary: The COVID-19 pandemic caused millions of infections and deaths globally, highlighting the urgent need for effective treatment options against new variants. Researchers have developed an innovative immunotherapeutic drug based on the SARS-CoV-2 entry receptor ACE2, which has shown promising results in neutralizing the virus and eliminating infected cells.

FRONTIERS IN IMMUNOLOGY (2023)

News Item Virology

Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family Flaviviridae

Thomas S. Postler, Martin Beer, Bradley J. Blitvich, Jens Bukh, Xavier de Lamballerie, J. Felix Drexler, Allison Imrie, Amit Kapoor, Galina G. Karganova, Philippe Lemey, Volker Lohmann, Peter Simmonds, Donald B. Smith, Jack T. Stapleton, Jens H. Kuhn

Summary: This review provides an overview of the recent changes in genus and species nomenclature within the virus family Flaviviridae. The changes were made to address potential ambiguity and to adhere to binomial format conventions. The genus name Flavivirus was changed to Orthoflavivirus, and all species names were modified accordingly. The revised taxonomy of the Flaviviridae family approved by the ICTV in April 2023 is outlined.

ARCHIVES OF VIROLOGY (2023)

Article Infectious Diseases

Seroprevalence of Dengue, Chikungunya and Zika at the epicenter of the congenital microcephaly epidemic in Northeast Brazil: A population-based survey

Cynthia Braga, Celina M. T. Martelli, Wayner Souza, Carlos D. Luna, Maria de Fatima P. M. Albuquerque, Carolline Mariz, Clarice N. L. Morais, Carlos A. A. Brito, Carlos Frederico C. A. Melo, Roberto Lins, Jan Felix Drexler, Thomas Jaenisch, Ernesto T. A. Marques, Isabelle F. T. Viana

Summary: A seroepidemiological study conducted in Recife, Brazil revealed that at least 34.6% of the population had been infected with Zika virus, with age and socioeconomic status influencing the infection rate. The study provides insight into the transmission dynamics of ZIKV and CHIKV in the region, and highlights the presence of a significant proportion of susceptible individuals in the population.

PLOS NEGLECTED TROPICAL DISEASES (2023)

Article Immunology

Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in Ecuador, a resource-limited setting

Andres Moreira-Soto, Alfredo Bruno, Domenica de Mora, Michelle Paez, Jimmy Garces, Ben Wulf, Anna-Lena Sander, Maritza Olmedo, Maria Jose Basantes Mantilla, Manuel Gonzalez Gonzalez, Solon Alberto Orlando, Silvia Salgado Cisneros, Juan Carlos Zevallos, Jan Felix Drexler

Summary: Despite the early implementation of non-pharmaceutical interventions (NPIs), Ecuador experienced a significant number of COVID-19 deaths in 2020. The study suggests that the high proportion of informal labor and human mobility in resource-limited settings like Ecuador may question the effectiveness of NPIs.

EMERGING MICROBES & INFECTIONS (2023)

Article Microbiology

Virulent Brucella nosferati infecting Desmodus rotundus has emerging potential due to the broad foraging range of its bat host for humans and wild and domestic animals

Gabriela Hernandez-Mora, Carlos Chacon-Diaz, Andres Moreira-Soto, Osvaldo Barrantes-Granados, Marcela Suarez-Esquivel, Eunice Viquez-Ruiz, Elias Barquero-Calvo, Nazareth Ruiz-Villalobos, Daniela Hidalgo-Montealegre, Rocio Gonzalez-Barrientos, Elena A. Demeter, Josimar Estrella-Morales, Ana-Mariel Zuniga-Pereira, Carlos Quesada-Gomez, Esteban Chaves-Olarte, Bruno Lomonte, Caterina Guzman-Verri, Jan Felix Drexler, Edgardo Moreno

Summary: In a tropical rainforest in Costa Rica, 47.89% of vampire bats were found to be infected with dangerous Brucella bacteria, causing placentitis and fetal death. These bats forage on a variety of animals, including humans.

MSPHERE (2023)

Article Public, Environmental & Occupational Health

Serological evidence for potential yellow fever virus infection in non-human primates, southeastern Mexico

Monica Salas-Rojas, Edmilson Ferreira de Oliveira-Filho, Cenia Almazan-Marin, Alba Zulema Rodas-Martinez, Alvaro Aguilar-Setien, Jan Felix Drexler

Summary: A serologic study in southeastern Mexico detected antibodies against yellow fever virus (YFV) and other flaviviruses in non-human primates, suggesting the circulation of YFV in areas previously considered free of the virus.

ONE HEALTH OUTLOOK (2023)

No Data Available